The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response

Circulation

Volumn 114, Issue 15, 2006, Pages 1599-1607

  Van Loosdregt, Jorg ^a   Van Oosterhout, Matthijs F M ^a   Bruggink, Annette H ^a   Van Wichen, Dick F ^a   Van Kuik, Joyce ^a   De Koning, Erica ^a   Baan, Carla C ^b   De Jonge, Nicolaas ^a   Gmelig Meyling, Frits H J ^a   De Weger, Roel A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arteriosclerosis; Cardiovascular diseases; Chemokines; Heart failure; Immunology; Pathology; Transplantation

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD79A ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; RANTES; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ADVENTITIA; AGED; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CD4 CD8 RATIO; CELL INFILTRATION; CLINICAL ARTICLE; CORONARY ARTERY; CYTOKINE RELEASE; FEMALE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INTIMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ADOLESCENT; ADULT; AGED; CARDIAC OUTPUT, LOW; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FEMALE; GENE EXPRESSION REGULATION; GRAFT REJECTION; HEART TRANSPLANTATION; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC MEMORY; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TH1 CELLS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA;

EID: 33749595579     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.597526     Document Type: Article

References (33)

1. Segovia J. Update on cardiac allograft vasculopathy. Curr Opin Organ Transplant. 2002;7:240-251.
2. Weis M, von Scheidt W. Coronary artery disease in the transplanted heart. Annu Rev Med. 2000;51:81-100.
3. Weis M, von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation. 1997;96:2069-2077.
4. Waller J, Brook NR, Nicholson ML. Cardiac allograft vasculopathy: current concepts and treatment. Transpl Int. 2003;16:367-375.
5. Costanzo MR, Naftel DC, Pritzker MR, Heilman JK 3rd, Boehmer JP, Brozena SC, Dec GW, Ventura HO, Kirklin JK, Bourge RC, Miller LW. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors: Cardiac Transplant Research Database. J Heart Lung Transplant. 1998;17:744-753.
6. Julius BK, Attenhofer Jost CH, Sutsch G, Brunner HP, Kuenzli A, Vogt PR, Turina M, Hess OM, Kiowski W. Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation. Transplantation. 2000;69:847-853.
7. Yamani MH, Yousufuddin M, Starling RC, Tuzco M, Ratliff NB, Cook DJ, Abdo A, Crowe T, Hobbs R, Rincon G, Bott-Silverman C, McCarthy PM, Young JB. Does acute cellular rejection correlate with cardiac allograft vasculopathy? J Heart Lung Transplant. 2004;23:272-276.
8. Zhao DX, Miller GG, Luster AD, Mitchell RN, Libby P. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol. 2002;169:1556-1560.
9. Nagano H, Libby P, Taylor MK, Hasegawa S, Stinn JL, Becker G, Tilney NL, Mitchell RN. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. Am J Pathol. 1998;152:1187-1197.
10. Shimizu K, Mitchell RN. Chemokine-mediated recruitment of inflammatory and smooth muscle cells in transplant-associated arteriosclerosis. Curr Opin Organ Transplant. 2003;8:55-63.
11. Yun JJ, Fischbein MP, Whiting D, Irie Y, Fishbein MC, Burdick MD, Belperio J, Strieter RM, Laks H, Berliner JA, Ardehali A. The role of MIG/CXCL9 in cardiac allograft vasculopathy. Am J Pathol. 2002;161:1307-1313.
12. Yun JJ, Fischbein MP, Laks H, Fishbein MC, Espejo ML, Ebrahimi K, Irie Y, Berliner J, Ardehali A. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy. Transplantation. 2001;69:2515-2524.
13. Yun JJ, Fischbein MP, Laks H, Irie Y, Espejo ML, Fishbein MC, Berliner JA, Ardehali A. RANTES production during development of cardiac allograft vasculopathy. Transplantation. 2001;71:1649-1656.
14. Umehara H, Bloom E, Okazaki T, Domae N, Imai T. Fractalkine and vascular injury. Trends Immunol. 2001;22:602-607.
15. Kao J, Kobashigawa J, Fishbein MC, MacLellan WR, Burdick MD, Belperio JA, Strieter RM. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease. Circulation. 2003;107:1958-1961.
16. Pattison JM, Nelson PJ, Huie P, Sibley RK, Krensky AM. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant. 1996;15:1194-1199.
17. Wang Y, Burns WR, Tang PC, Yi T, Schrechner JS, Zerwes HG, Sessa WC, Lorber MI, Pober JS, Tellides G. Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. FASEB J. 2004;18:606-608.
18. Koh KP, Wang Y, Yi T, Shiao SL, Lorber MI, Sessa WC, Tellides G, Pober JS. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest. 2004;114:846-856.
19. de Jonge N, van Wichen DF, van Kuik J, Kirkels H, Lahpor JR, Gmelig-Meyling FH, van der Tweel JG, de Weger RA. Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. J Heart Lung Transplant. 2003;22:1028-1036.
20. van Hoffen E, van Wichen DF, Leemans JC, Broekhuizen RA, Bruggink AH, De Boer M, De Jonge N, Kirkels H, Slootweg PJ, Gmelig-Meyling FH, De Weger RA. T cell apoptosis in human heart allografts: association with lack of co-stimulation? Am J Pathol. 1998;153:1813-1824.
21. Atkinson C, Horsley J, Rhind-Tutt S, Charman S, Phillpotts CJ, Wallwork J, Goddard MJ. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. J Heart Lung Transplant. 2004;23:427-435.
22. Atkinson C, Southwood M, Pitman R, Phillpotts C, Wallwork J, Goddard M. Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy. J Heart Lung Transplant. 2005;24:551-558.
23. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med. 2001;193:975-980.
24. Whiting D, Hsieh G, Yun JJ, Banerji A, Yao W, Fishbein MC, Belperio J, Strieter RM, Bonavida B, Ardehali A. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J Immunol. 2004;172:7417-7424.
25. Gao W, Faia KL, Csizmadia V, Smiley ST, Soler D, King JA, Danoff TN, Hancock WW. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation. 2001;72:1199-1205.
26. Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D, Fishbein MC, Proudfoot AE, Laks H, Berliner JA, Ardehali A. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation. 2004;109:932-937.
27. Horiguchi K, Kitagawa-Sakakida S, Sawa Y, Li ZZ, Fukashima N, Shirakura R, Matsuda H. Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy. J Heart Lung Transplant. 2002;21:1090-1100.
28. Melter M, Exeni A, Reinders MEJ, Fang JC, McMahon G, Ganz P, Hancock WW, Briscoe DM. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation. 2001;104:2558-2564.
29. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest. 2001;107:1173-1181.
30. Burns WR, Wang Y, Tang PCY, Ranjbaran H, Iakimov A, Kim J, Cuffy M, Bai Y, Pober JS, Tellides G. Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-γ-inducible chemokines in rejecting human arteries. Am J Transplant. 2005;5:1226-126.
31. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and MIG: structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996;184:963-996.
32. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today. 1998;19:568-574.
33. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677-686.